ScienceMachine, a London-based AI startup, has secured $3.5 million in pre-seed funding to accelerate the adoption of autonomous artificial intelligence in biotech research. The company’s flagship pro...

SciencemachineA British AI Startup has fully accelerated biotech data analysis with autonomous agents, raised € 2.9 million pre-marks funding for sales and pharma partnerships, especially to support product development and appointment. The round was led by Juniper and strategic aspirations, led by Revent and Nucleus Capital. "Our goal is to help make the bioforma groundbreaking discoveries faster and cheaper," Say Lorenzo SaniCEO and co-founder of Sciencemachin. "Our AI agent works twenty -four hours, analyzing the data of research from the lab to the clinic, raw data turns into breakthroughs in a few hours instead of a few months…

Reported Tuesday, Apr 28 - 8:56am EDT (TheFly subscription required to read more.)

ScienceMachine lands early stage funding for bioinformatician agent that can turn ‘raw data into breakthroughs in hours, instead of months.’

Modern bioinformatics research is characterized by the constant emergence of complex data sources and analytical challenges. Researchers routinely confront tasks that require the synthesis of diverse datasets, the execution of iterative analyses, and the…

ScienceMachine’s flagship product, Sam, acts as an always-on AI bioinformatician, helping scientists extract insights from their research faster, more accurately, and at a lower cost.